1985
Isotretinoin therapy for progressive systemic sclerosis
Search citation statements
Paper Sections
Select...
6
3
2
0
Citation Types
0
6
0
0
Year Published
1987
2018
Publication Types
Select...
8
1
Relationship
0
9
Authors
Journals
Cited by 9 publications
(6 citation statements)
References 0 publications
0
6
0
0
“…ATRA has been reported to control and modulate the autoimmune diseases and has a clinically significant therapeutic effect on SSc [ 20 , 21 ]. In this study, we treated SSc CD4+ T cells with or without TGF- β and/or ATRA in vitro .…”
Section: Discussion
mentioning
confidence: 99%
“…ATRA has been reported to control and modulate the autoimmune diseases and has a clinically significant therapeutic effect on SSc [ 20 , 21 ]. In this study, we treated SSc CD4+ T cells with or without TGF- β and/or ATRA in vitro .…”
Section: Discussion
mentioning
confidence: 99%
“…Retinoic acids (RA) have been reported to induce clinically significant therapeutic effects on SSc [ 20 , 21 ]. However, the underlying molecular mechanism of RA in the prevention of SSc remains unclear.…”
Section: Introduction
mentioning
confidence: 99%
“…The usefulness of retinoids (retinoic acid) in treating skin sclerosis of systemic scleroderma has been reported in the literature [ 1 , 2 , 7 ]. Retinoids decrease collagen synthesis [ 8 ].…”
Section: Discussion
mentioning
confidence: 99%
“…Systemic or topical retinoids have been reported to be a successful treatment for skin sclerosis due to systemic sclerosis. 10,11 It was suggested that oral etretinate treatment may be a plausible new therapy for sclerodermatous chronic graft-versus-host disease. 12 Our results were thought to support this trend.…”
Section: Discussion
mentioning
confidence: 99%
